Eton Pharmaceuticals, Inc. Increase (Decrease) in Accounts Payable
Eton Pharmaceuticals, Inc. (ETON) reported Increase (Decrease) in Accounts Payable of $3.43 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-13
- Eton Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $921.00K, a 87.32% decline year-over-year.
- Eton Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $2.51M, a 255.74% increase year-over-year.
- Eton Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$3.28M, a 321.59% decline year-over-year.
- Eton Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $2.12M, a 284.42% increase year-over-year.
- Eton Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2025 was $6.81M, a 193.70% increase from fiscal 2024.
- Eton Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2024 was $2.32M, a 4273.58% increase from fiscal 2023.
- Eton Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2023 was $53.00K.
- Eton Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2022 was -$8.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 5 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 8 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $921.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $3.43M 10-Q · filed 2026-08-13 | $145.00K derived: sum of 3 quarters · filed 2026-08-13 | $2.27M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $2.51M 10-Q · filed 2026-05-14 | -$776.00K derived: sum of 2 quarters · filed 2026-05-14 | $1.35M derived: sum of 3 quarters · filed 2026-05-14 | $8.61M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | -$3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$1.16M derived: sum of 2 quarters · filed 2026-03-19 | $6.10M derived: sum of 3 quarters · filed 2026-08-13 | $6.81M 10-K · filed 2026-03-19 | |||
| 2025-09-30 | $2.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $9.39M derived: sum of 2 quarters · filed 2026-08-13 | $10.09M 10-Q · filed 2025-11-06 | $11.57M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $7.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $7.97M 10-Q · filed 2026-08-13 | $9.45M derived: sum of 3 quarters · filed 2026-08-13 | $10.00M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | $705.00K 10-Q · filed 2026-05-14 | $2.19M derived: sum of 2 quarters · filed 2026-05-14 | $2.74M derived: sum of 3 quarters · filed 2026-05-14 | $2.61M derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $2.03M derived: sum of 2 quarters · filed 2026-03-19 | $1.90M derived: sum of 3 quarters · filed 2026-03-19 | $2.32M 10-K · filed 2026-03-19 | |||
| 2024-09-30 | $552.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $422.00K derived: sum of 2 quarters · filed 2025-11-06 | $836.00K 10-Q · filed 2025-11-06 | $941.00K derived: sum of 4 quarters · filed 2026-03-19 | |||
| 2024-06-30 | -$130.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $284.00K 10-Q · filed 2025-08-07 | $389.00K derived: sum of 3 quarters · filed 2026-03-19 | -$200.00K derived: sum of 4 quarters · filed 2026-03-19 | |||
| 2024-03-31 | $414.00K 10-Q · filed 2025-05-13 | $519.00K derived: sum of 2 quarters · filed 2026-03-19 | -$70.00K derived: sum of 3 quarters · filed 2026-03-19 | $997.00K derived: sum of 4 quarters · filed 2026-03-19 | |||
| 2023-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$484.00K derived: sum of 2 quarters · filed 2026-03-19 | $583.00K derived: sum of 3 quarters · filed 2026-03-19 | $53.00K 10-K · filed 2026-03-19 | |||
| 2023-09-30 | -$589.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $478.00K derived: sum of 2 quarters · filed 2024-11-12 | -$52.00K 10-Q · filed 2024-11-12 | $660.00K derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $537.00K 10-Q · filed 2024-08-08 | $1.25M derived: sum of 3 quarters · filed 2025-03-18 | $1.00M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-03-31 | -$530.00K 10-Q · filed 2024-05-09 | $182.00K derived: sum of 2 quarters · filed 2025-03-18 | -$63.00K derived: sum of 3 quarters · filed 2025-03-18 | -$145.00K derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2022-12-31 | $712.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $467.00K derived: sum of 2 quarters · filed 2025-03-18 | $385.00K derived: sum of 3 quarters · filed 2025-03-18 | -$8.00K 10-K · filed 2025-03-18 | |||
| 2022-09-30 | -$245.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$327.00K derived: sum of 2 quarters · filed 2023-11-09 | -$720.00K 10-Q · filed 2023-11-09 | -$1.99M derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2022-06-30 | -$82.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$475.00K 10-Q · filed 2023-08-10 | -$1.74M derived: sum of 3 quarters · filed 2024-03-14 | -$223.00K derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2022-03-31 | -$393.00K 10-Q · filed 2023-05-11 | -$1.66M derived: sum of 2 quarters · filed 2024-03-14 | -$141.00K derived: sum of 3 quarters · filed 2024-03-14 | -$380.00K derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2021-12-31 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $252.00K derived: sum of 2 quarters · filed 2024-03-14 | $13.00K derived: sum of 3 quarters · filed 2024-03-14 | -$570.00K 10-K · filed 2024-03-14 | |||
| 2021-09-30 | $1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.28M derived: sum of 2 quarters · filed 2022-11-10 | $699.00K 10-Q · filed 2022-11-10 | $929.00K 10-Q · filed 2021-11-16 | $835.00K derived: sum of 4 quarters · filed 2023-03-16 | ||
| 2021-06-30 | -$239.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$822.00K 10-Q · filed 2022-08-11 | -$686.00K derived: sum of 3 quarters · filed 2023-03-16 | -$431.00K derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-03-31 | -$583.00K 10-Q · filed 2022-05-12 | -$447.00K derived: sum of 2 quarters · filed 2023-03-16 | -$192.00K derived: sum of 3 quarters · filed 2023-03-16 | $578.00K derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2020-12-31 | $136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $391.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.16M derived: sum of 3 quarters · filed 2023-03-16 | $1.77M 10-K · filed 2023-03-16 | |||
| 2020-09-30 | $255.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-16 | $1.02M derived: sum of 2 quarters · filed 2021-11-16 | $1.63M 10-Q · filed 2021-11-16 | $1.66M derived: sum of 4 quarters · filed 2022-03-16 | |||
| 2020-06-30 | $770.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $1.38M 10-Q · filed 2021-08-16 | $1.40M derived: sum of 3 quarters · filed 2022-03-16 | $1.07M derived: sum of 4 quarters · filed 2022-03-16 | |||
| 2020-03-31 | $608.00K 10-Q · filed 2021-05-13 | $634.00K derived: sum of 2 quarters · filed 2022-03-16 | $300.00K derived: sum of 3 quarters · filed 2022-03-16 | -$1.50M derived: sum of 4 quarters · filed 2022-03-16 | |||
| 2019-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | -$308.00K derived: sum of 2 quarters · filed 2022-03-16 | -$2.11M derived: sum of 3 quarters · filed 2022-03-16 | -$377.00K 10-K · filed 2022-03-16 | |||
| 2019-09-30 | -$334.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$2.14M derived: sum of 2 quarters · filed 2020-11-12 | -$403.00K 10-Q · filed 2020-11-12 | -$244.00K derived: sum of 4 quarters · filed 2021-03-16 | |||
| 2019-06-30 | -$1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$69.00K 10-Q · filed 2020-08-12 | $90.00K derived: sum of 3 quarters · filed 2021-03-16 | $15.00K derived: sum of 4 quarters · filed 2021-03-16 | |||
| 2019-03-31 | $1.74M 10-Q · filed 2020-05-14 | $1.90M derived: sum of 2 quarters · filed 2021-03-16 | $1.82M derived: sum of 3 quarters · filed 2021-03-16 | $1.89M derived: sum of 4 quarters · filed 2021-03-16 | |||
| 2018-12-31 | $159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $84.00K derived: sum of 2 quarters · filed 2021-03-16 | $151.00K derived: sum of 3 quarters · filed 2021-03-16 | $413.00K 10-K · filed 2021-03-16 | |||
| 2018-09-30 | -$75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$8.00K derived: sum of 2 quarters · filed 2019-11-14 | $254.00K 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $329.00K 10-Q · filed 2019-08-06 | |||||
| 2018-03-31 | $262.00K 10-Q · filed 2019-05-07 | ||||||
| 2017-12-31 | $539.00K 10-K · filed 2020-03-05 | ||||||
| 2017-09-30 | $227.00K 10-Q · filed 2018-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |